ebook Munafa Stock Market Course + Intraday & FNO calls  

       

506235 announcements Alembic Ltd. announcements and dividends declared BSE

Alembic Ltd. Complete list of announcements declared & dividend announcements by Alembic Ltd. 506235

Alembic Ltd. 506235 listed on BSE and deals in

Announcements and dividends declared by Alembic Ltd. 506235

Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gel
Alembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval, for the 5% strength, means the company can now market its version, which is therapeutically equivalent to Almirall's
Announcement as on 29 June 2026

Alembic Pharma gets tentative nod from USFDA for generic cancer drug
Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step for the company in the cancer treatment drug market. The approval is for the 45mg strength, with potential for marketin
Announcement as on 19 June 2026

Alembic gets USFDA nod for generic levothyroxine sodium tablets
Alembic Pharmaceuticals has secured final approval from the US health regulator for its generic levothyroxine sodium tablets. This medication is used as a replacement therapy for hypothyroidism. The approval covers multiple strengths of the tablets. This d
Announcement as on 22 May 2026

Alembic Pharma gets USFDA tentative nod for generic prostate cancer drug
Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic version of Darolutamide tablets, targeting prostate cancer treatment. The approval is for the 300 mg strength. The drug is a generic version of Nubeqa Tablets. The robust
Announcement as on 14 May 2026

Alembic Pharma gets USFDA nod for generic cancer, arthritis injection
Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its generic methotrexate injection, used to treat multiple cancers and arthritis conditions. The approval covers key dosage formats and confirms therapeutic eq
Announcement as on 16 April 2026

Announcements by Alembic Ltd. first page | Next page |

506235 Alembic Ltd. current price & indicator signals

Moving Averages for Alembic Ltd.

  • 5Day Average: 91.88
  • 12Day Average: 91.77
  • 20Day Average: 89.91
  • 50Day Average: 90.08
  • 100Day Average: 88.78
  • 150Day Average: 91.98
  • 200Day Average: 94.37

506235 Indicators & signals

Indicator MACD (12,26,9)

91.36, 90.27, 0.8
Indicator MACD is in positive zone

Indicator ADX (14)

36.63, 28.87, 13.39
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 506235 Alembic Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
03 Fri Jul 2026 92.82 92.26 to 94.00 -0.54% 0.33 times
02 Thu Jul 2026 93.32 91.31 to 93.83 1.94% 0.73 times
01 Wed Jul 2026 91.54 91.30 to 92.88 0.2% 0.38 times
30 Tue Jun 2026 91.36 90.34 to 92.25 1.13% 0.23 times
29 Mon Jun 2026 90.34 90.00 to 91.97 -1.36% 0.41 times
25 Thu Jun 2026 91.59 91.42 to 93.06 -0.59% 0.26 times
24 Wed Jun 2026 92.13 91.39 to 93.00 -0.07% 1.32 times
23 Tue Jun 2026 92.19 91.01 to 95.36 1.09% 1.59 times
22 Mon Jun 2026 91.20 90.57 to 92.09 1.21% 1.23 times
19 Fri Jun 2026 90.11 89.60 to 94.28 -3.91% 1.85 times
18 Thu Jun 2026 93.78 91.75 to 95.65 3.2% 2.01 times
17 Wed Jun 2026 90.87 88.97 to 91.59 1.88% 0.87 times

Videos related to: 506235 announcements Alembic Ltd. announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

506235 announcements Alembic Ltd. announcements and dividends declared BSE

 

Back to top